市場調査レポート
商品コード
1404567

臓器チップ(Organ-on-a-chip)の市場規模、シェア、動向分析レポート:製品・サービス別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年

Organ On A Chip Market Size, Share & Trends Analysis Report By Product & Service (Products, Services), By Application (Drug Discovery, Toxicology Research), By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
臓器チップ(Organ-on-a-chip)の市場規模、シェア、動向分析レポート:製品・サービス別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2023年11月01日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臓器チップ(Organ-on-a-chip)市場の成長と動向:

Grand View Research社の最新レポートによると、世界の臓器チップ(Organ-on-a-chip)市場規模は2030年までに9億5,240万米ドルに達すると予測されています。

2024年から2030年までのCAGRは35.01%と予測されています。慢性疾患の有病率の増加、創薬ニーズの高まり、民間および公的企業からの投資や資金調達の増加などの要因が、市場成長の原動力になると予想されます。また、製薬・バイオテクノロジー企業や学術・研究機関からの需要の高まりによる市場競争の激化も、予測期間中の業界成長を促進すると予想されます。

さらに、効率的な創薬技術に対する需要の高まり、特に慢性疾患の有病率上昇の背景が、市場成長の原動力となっています。例えば、2023年7月、NETRIはAxion BioSystemsと提携して、NeuroFluidics MEAラインの発売を発表しました。この製品ラインは、アクシオンのMaestro MultiElectrode Array(MEA)システムと互換性があり、MEA層を備えたユニークなコンパートメント型マイクロ流体機器を紹介しています。これらのすぐに使用可能なプラットフォームは、臓器チップ(Organ-on-a-chip)・アプリケーションのための高スループット・ソリューションを提供し、神経学、皮膚科学、および疾患研究や創薬に重要な他の分野における高度な研究を促進します。

さらに、肝臓オンチップセグメントは、生物医学研究と医薬品開発を進める上で重要な役割を果たすことから、臓器チップ(Organ-on-a-chip)産業の重要な牽引役となっています。例えば、2023年9月、臓器チップ(Organ-on-a-chip)業界の主要プレーヤーであるCN Bio社は、全ヒト研究ソリューションの専門知識で世界的に認知されている非営利団体LifeNet Health LifeSciences社と提携しました。この提携は、CN Bio社のフィジオミミックスOOCシリーズにライフネット・ヘルス社の検証済み初代ヒト細胞を供給することを目的としています。この契約において、ライフネット・ヘルス社は、CNバイオ社の非アルコール性脂肪肝炎(NASH)用「in-a-box」キットを通じて、あるいはライフネット・ヘルス社から直接入手できる、最高品質のMPS検証済み肝細胞を提供しました。

さらに、北米は2023年に臓器チップ(Organ-on-a-chip)業界を支配し、予測期間中に最も速いCAGRで成長すると予測されています。この成長の背景には、同地域における主要市場企業の存在と政府の取り組みがあります。例えば、2023年3月、Bayer AGはesqLABSおよびDynamic42と提携しました。彼らは、ヘルスケア産業における医薬品開発のための動物実験を減らすために、1年間の臓器チップ(Organ-on-a-chip)パイロットプログラムを導入しました。このようなビジネスイニシアチブは、北米地域の市場成長に貢献すると予想されます。

臓器チップ(Organ-on-a-chip)市場レポートハイライト

  • 製品・サービス別では、サービス分野が2023年の収益貢献が大きく、製品分野は慢性疾患の有病率上昇により2030年までに36.20%のCAGRを記録すると予測されています。
  • 用途別では、創薬分野が2023年に62.87%のシェアで世界の業界を支配しました。しかし、毒物学調査セグメントは予測期間中に最も高い成長率を記録すると予測されています。
  • 最終用途に基づくと、学術・研究機関セグメントは予測期間中に39.27%の最速CAGRを記録すると予測されています。しかし、製薬・バイオテクノロジー企業セグメントは、2023年に73.03%のシェアを占め、業界の最大収益を生み出しました。
  • 地域別では、北米が2023年に50.23%の収益シェアで世界業界を支配しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
  • 市場力学
  • 業界分析ツール

第4章 製品およびサービスのビジネス分析

  • 臓器チップ(Organ-on-a-chip)市場:製品およびサービスの変動分析
  • 製品
    • 製品市場、2018年~2030年
    • 機器
    • 臓器チップ(Organ-on-a-chip)デバイス
  • サービス
    • サービス市場、2018年~2030年

第5章 用途ビジネス分析

  • 臓器チップ(Organ-on-a-chip)市場:用途変動分析
  • 創薬
  • 毒物学研究
  • その他

第6章 最終用途ビジネス分析

  • 臓器チップ(Organ-on-a-chip)市場:最終用途の変動分析
  • 学術研究機関
    • 学術研究機関市場、2018年~2030年
  • 製薬・バイオテクノロジー企業
    • 製薬・バイオテクノロジー企業市場、2018年~2030年
  • その他
    • その他市場、2018年~2030年

第7章 地域ビジネス分析

  • 地域別臓器チップ(Organ-on-a-chip)市場シェア、2023年および2030年
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市況分析、2023年
  • 企業プロファイル・一覧表
    • Emulate, Inc.
    • MIMETAS BV
    • Valo Health
    • Nortis, Inc.
    • AxoSim
    • BICO-THE BIO CONVERGENCE COMPANY
    • CN Bio Innovations Ltd
    • SynVivo, Inc.
    • The Charles Stark Draper Laboratory, Inc.
    • AlveoliX AG
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 4 Global Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 5 Global Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 6 Global Organ-on-a-Chip Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 North America Organ-on-a-Chip Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 9 North America Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 10 North America Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 12 U.S. Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 14 Canada Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 15 Canada Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 17 Europe Organ-on-a-Chip Market, By Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 19 Europe Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Europe Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 21 UK Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 22 UK Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 UK Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 24 Germany Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 25 Germany Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 Germany Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 27 France Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 28 France Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 France Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 30 Spain Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 31 Spain Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 Spain Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 33 Italy Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 34 Italy Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 Italy Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 36 Denmark Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 37 Denmark Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Denmark Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 39 Norway Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 40 Norway Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Norway Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 43 Sweden Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Organ-on-a-Chip Market, By Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 49 China Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 50 China Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 China Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 52 Japan Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 53 Japan Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 Japan Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 55 India Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 56 India Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 India Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 58 South Korea Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 59 South Korea Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 South Korea Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 61 Australia Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 62 Australia Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Australia Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 64 Thailand Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 65 Thailand Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Thailand Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America Organ-on-a-Chip Market, By Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 69 Latin America Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Latin America Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 72 Brazil Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 73 Brazil Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 75 Mexico Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Mexico Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 78 Argentina Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 80 MEA Organ-on-a-Chip Market, By Country, 2018 - 2030 (USD Million)
  • Table 81 MEA Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 82 MEA Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 83 MEA Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 85 South Africa Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 87 UAE Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 88 UAE Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 UAE Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Organ-on-a-Chip Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Organ-on-a-Chip Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Organ-on-a-Chip Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Figure 1. Market research process
  • Figure 2. Information procurement
  • Figure 3. Primary research pattern
  • Figure 4. Market research approaches
  • Figure 5. Value chain-based sizing & forecasting
  • Figure 6. Market formulation & validation
  • Figure 7. Organ-on-a-chip market segmentation
  • Figure 8. Market snapshot, 2023
  • Figure 9. Market trends & outlook
  • Figure 10. Market driver relevance analysis (current & future impact)
  • Figure 11. Market restraint relevance analysis (current & future impact)
  • Figure 12. PESTEL analysis
  • Figure 13. Porter's five forces analysis
  • Figure 14. Global organ-on-a-chip market: Product & service outlook and key takeaways
  • Figure 15. Global organ-on-a-chip market: Product & service movement analysis
  • Figure 16. Global organ-on-a-chip market, for products, 2018 - 2030 (USD Million)
  • Figure 17. Global organ-on-a-chip market, for instruments, 2018 - 2030 (USD Million)
  • Figure 18. Global organ-on-a-chip market, for organ-on-a-chip devices, 2018 - 2030 (USD Million)
  • Figure 19. Global organ-on-a-chip market, for liver-on-a-chip, 2018 - 2030 (USD Million)
  • Figure 20. Global organ-on-a-chip market, for lung-on-a-chip, 2018 - 2030 (USD Million)
  • Figure 21. Global organ-on-a-chip market, for intestine-on-a-chip, 2018 - 2030 (USD Million)
  • Figure 22. Global organ-on-a-chip market, for kidney-on-a-chip, 2018 - 2030 (USD Million)
  • Figure 23. Global organ-on-a-chip market, for heart-on-a-chip, 2018 - 2030 (USD Million)
  • Figure 24. Global organ-on-a-chip market, for others, 2018 - 2030 (USD Million)
  • Figure 25. Global organ-on-a-chip market, for services, 2018 - 2030 (USD Million)
  • Figure 26. Global organ-on-a-chip market: Application outlook and key takeaways
  • Figure 27. Global organ-on-a-chip market: Application movement analysis
  • Figure 28. Global organ-on-a-chip market, for drug discovery, 2018 - 2030 (USD Million)
  • Figure 29. Global organ-on-a-chip market, for toxicology research, 2018 - 2030 (USD Million)
  • Figure 30. Global organ-on-a-chip market, for others, 2018 - 2030 (USD Million)
  • Figure 31. Global organ-on-a-chip market: End-use outlook and key takeaways
  • Figure 32. Global organ-on-a-chip market: End-use movement analysis
  • Figure 33. Global organ-on-a-chip market, for academic and research institutes, 2018 - 2030 (USD Million)
  • Figure 34. Global organ-on-a-chip market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • Figure 35. Global organ-on-a-chip market, for others, 2018 - 2030 (USD Million)
  • Figure 36. Regional marketplace: Key takeaways
  • Figure 37. Regional outlook, 2023 & 2030
  • Figure 38. Global organ-on-a-chip market: Region movement analysis
  • Figure 39. North America organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 40. U.S. organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 41. Canada organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 42. Europe organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 43. Germany organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 44. UK organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 45. France organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 46. Italy organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 47. Spain organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 48. Denmark organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 49. Sweden organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 50. Norway organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 51. Asia Pacific organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 52. Japan organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 53. China organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 54. India organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 55. Australia organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 56. South Korea organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 57. Thailand organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 58. Latin America organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 59. Brazil organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 60. Mexico organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 61. Argentina organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 62. Middle East and Africa organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 63. South Africa organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 64. Saudi Arabia organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 65. UAE organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Figure 66. Kuwait organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-148-6

Organ On A Chip Market Growth & Trends:

The global organ on a chip market size is anticipated to reach USD 952.4 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to register a CAGR of 35.01% from 2024 to 2030. Factors such as the increasing prevalence of chronic disease, the rising need for drug discovery, and growing investment and funding from private and public players are expected to drive the market growth. In addition, increasing competition in the market owing to rising demand from pharmaceutical & biotechnology companies and academic & research institutions is also anticipated to propel the industry growth over the forecast period.

Moreover, the increasing demand for efficient drug discovery techniques, particularly in the context of the rising prevalence of chronic diseases is driving the market growth. For instance, in July 2023, NETRI, in partnership with Axion BioSystems, announced the launch of the NeuroFluidics MEA line. This product line, compatible with Axion's Maestro MultiElectrode Array (MEA) systems, introduces a unique range of compartmentalized microfluidic instruments with an MEA layer. These ready-to-use platforms offer high-throughput solutions for organs-on-chip applications, facilitating advanced research in neurology, dermatology, and other fields crucial for disease study and drug discovery.

Moreover, the liver-on-a-chip segment is a significant driver of the organ-on-a-chip industry, driven by its key role in advancing biomedical research and drug development. For instance, in September 2023, CN Bio, a key player in the organ-on-a-chip industry, collaborated with LifeNet Health LifeSciences, a nonprofit organization recognized globally for its expertise in all-human research solutions. The collaboration aims to supply CN Bio's PhysioMimix OOC range with validated primary human cells from LifeNet Health. In this agreement, LifeNet Health provided supreme-quality, MPS-validated hepatic cells that can be accessed through CN Bio's 'in-a-box' kit for Non-Alcoholic Steatohepatitis (NASH), or directly from LifeNet Health.

Furthermore, North America dominated the organ-on-a-chip industry in 2023 and is projected to grow at the fastest CAGR over the forecast period. The growth is attributed to the presence of key market players in the region and government initiatives. For instance, in March 2023, Bayer AG collaborated with esqLABS and Dynamic42. They introduced a one-year organ-on-a-chip pilot program to reduce testing on animals for drug development in the healthcare industry. Such business initiatives are anticipated to contribute to the growth of the market of the North America region.

Organ On A Chip Market Report Highlights:

  • Based on product & service, the services segment was the larger revenue contributor in 2023 while the products segment is anticipated to register the fastest CAGR of 36.20% by 2030 due to rising prevalence of chronic diseases
  • In terms of application, the drug discovery segment dominated the global industry with a share of 62.87% in 2023. However, the toxicology research segment is projected to register the highest growth rate during the projected period
  • Based on end-use, the academic and research institute segment is anticipated to register the fastest CAGR of 39.27% over the forecast period. However, the pharmaceutical and biotechnology companies segment generated the maximum revenue for the industry, with a share of 73.03% in 2023.
  • In terms of region, North America dominated the global industry in 2023 with a revenue share of 50.23% owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End-use Segment
  • 1.3. Information Analysis
  • 1.4. Market Formulation & Data Visualization
  • 1.5. Data Validation & Publishing
  • 1.6. Research Assumptions
  • 1.7. Information Procurement
    • 1.7.1. Primary Research
  • 1.8. Information or Data Analysis
  • 1.9. Market Formulation & Validation
  • 1.10. Market Model
  • 1.11. Global Market: CAGR Calculation
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Demand For Personalized Medicine
      • 3.2.1.2. Technological Advancements In Organ-On-A-Chip Technologies
      • 3.2.1.3. Increasing Applications Of Organ-On-A-Chip Models For Biomedical Research
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Technical Challenges And Complexities Associated With Organ-On-A-Chip Techniques
      • 3.2.2.2. Regulatory Hurdles Faced By Organ-On-A-Chip Methods
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product & Service Business Analysis

  • 4.1. Organ-on-a-Chip Market: Product & Service Movement Analysis
  • 4.2. Products
    • 4.2.1. Products Market, 2018 - 2030 (USD Million)
    • 4.2.2. Instruments
      • 4.2.2.1. Instruments Market, 2018 - 2030 (USD Million)
    • 4.2.3. Organ-on-a-Chip Devices
      • 4.2.3.1. Organ-on-a-Chip Devices Market, 2018 - 2030 (USD Million)
      • 4.2.3.2. Liver-on-a-Chip
      • 4.2.3.2.1. Liver-on-a-Chip Market, 2018 - 2030 (USD Million)
      • 4.2.3.3. Lung-on-a-Chip
      • 4.2.3.3.1. Lung-on-a-Chip Market, 2018 - 2030 (USD Million)
      • 4.2.3.4. Intestine-on-a-Chip
      • 4.2.3.4.1. Intestine-on-a-Chip Market, 2018 - 2030 (USD Million)
      • 4.2.3.5. Kidney-on-a-Chip
      • 4.2.3.5.1. Kidney-on-a-Chip Market, 2018 - 2030 (USD Million)
      • 4.2.3.6. Heart-on-a-Chip
      • 4.2.3.6.1. Heart-on-a-Chip Market, 2018 - 2030 (USD Million)
      • 4.2.3.7. Others
      • 4.2.3.7.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. Services
    • 4.3.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Organ-on-a-Chip Market: Application Movement Analysis
  • 5.2. Drug Discovery
    • 5.2.1. Drug Discovery Market, 2018 - 2030 (USD Million)
  • 5.3. Toxicology Research
    • 5.3.1. Toxicology Research Market, 2018 - 2030 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Organ-on-a-Chip Market: End-use Movement Analysis
  • 6.2. Academic and Research Institutes
    • 6.2.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.3. Pharmaceutical & Biotechnology Companies
    • 6.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Organ-on-a-Chip Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. U.S. Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Canada Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. UK Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Germany Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. France Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Italy Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Spain Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Denmark Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Sweden Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Norway Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Japan Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. China Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. India Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Australia Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Thailand Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. South Korea Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Brazil Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Mexico Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Argentina Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. South Africa Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Saudi Arabia Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. UAE Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Kuwait Organ-on-a-Chip Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Emulate, Inc.
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. MIMETAS B.V.
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Valo Health
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Nortis, Inc.
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. AxoSim
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. BICO - THE BIO CONVERGENCE COMPANY
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. CN Bio Innovations Ltd
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. SynVivo, Inc.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. The Charles Stark Draper Laboratory, Inc.
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. AlveoliX AG
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives